NUSAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.604800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.923000E-01
Normal-vs-Stage2
3.794600E-01
Normal-vs-Stage3
9.899200E-01
Normal-vs-Stage4
9.939000E-01
Stage1-vs-Stage2
4.764800E-01
Stage1-vs-Stage3
7.532000E-01
Stage1-vs-Stage4
7.622400E-01
Stage2-vs-Stage3
3.038600E-01
Stage2-vs-Stage4
3.070800E-01
Stage3-vs-Stage4
9.963800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.529800E-01
Normal-vs-AfricanAmerican
9.108600E-01
Normal-vs-Asian
3.868000E-01
Caucasian-vs-AfricanAmerican
3.635600E-01
Caucasian-vs-Asian
9.783200E-01
AfricanAmerican-vs-Asian
3.316000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.370400E-01
Normal-vs-Female
3.852800E-01
Male-vs-Female
2.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.720000E-01
Normal-vs-Age(41-60Yrs)
3.778400E-01
Normal-vs-Age(61-80Yrs)
5.005600E-01
Normal-vs-Age(81-100Yrs)
4.880200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.254400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.678600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.054000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.676390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.943200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.378800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.930000E-01
Normal-vs-Daily Drinker
4.188800E-01
Normal-vs-Weekly Drinker
5.701200E-01
Normal-vs-Occasional Drinker
4.878800E-01
Normal-vs-Social Drinker
4.826800E-01
Non Drinker-vs-Daily Drinker
7.723200E-01
Non Drinker-vs-Weekly Drinker
8.601400E-01
Non Drinker-vs-Occasional Drinker
9.958400E-01
Non Drinker-vs-Social Drinker
8.731000E-01
Daily Drinker-vs-Weekly Drinker
6.849400E-01
Daily Drinker-vs-Occasional Drinker
7.980000E-01
Daily Drinker-vs-Social Drinker
6.785800E-01
Weekly Drinker-vs-Occasional Drinker
8.664800E-01
Weekly Drinker-vs-Social Drinker
9.778800E-01
Occasional Drinker-vs-Social Drinker
8.756800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.911400E-01
Normal-vs-Grade 2
8.607400E-01
Normal-vs-Grade 3
9.027400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.810700E-04
Grade 1-vs-Grade 3
4.048200E-04
Grade 1-vs-Grade 4
6.911400E-01
Grade 2-vs-Grade 3
3.964800E-01
Grade 2-vs-Grade 4
8.607400E-01
Grade 3-vs-Grade 4
9.027400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.159400E-01
Normal-vs-NonDiabetic
4.025400E-01
Diabetic-vs-NonDiabetic
9.808200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.945900E-02
Normal-vs-NoPancreatitis
4.948400E-01
Pancreatitis-vs-NoPancreatitis
1.778580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.698600E-01
Normal-vs-N1
4.119200E-01
N0-vs-N1
4.553600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.174400E-02
Normal-vs-TP53-NonMutant
6.870400E-01
TP53-Mutant-vs-TP53-NonMutant
4.02869999582833E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
